Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE National Lung Cancer Partnership
Strategy Built on Four Goals of Research, Treatment, Tumor Testing and Clinical Trial Participation
MADISON, Wis., March 19, 2013 /PRNewswire-USNewswire/ -- Only 16 percent of people diagnosed with lung cancer survive five years; but that will soon change through a transformative effort by the National Lung Cancer Partnership to double the survival rate by 2022.
Lung cancer claims more than160,000 lives in the United States every year, more than any other cancer and more than breast, colon and prostate cancers combined. The five-year lung cancer survival rate has barely budged in the past decade, inching up from 15 percent to 16 percent. That's because most people aren't diagnosed until the disease is advanced, and their treatment options are limited. Research funding is vital to turning that around – including for the development of new, more effective therapies for treating lung cancer – but lags far behind that of other cancers.
"At the heart of this new vision is a promise that everyone diagnosed with lung cancer will have a greater chance of survival than ever before," said Joan Schiller, MD, president of the National Lung Cancer Partnership and chief of hematology/oncology at the University of Texas Southwestern Medical Center. "We're committed to the dedication, collaboration and inspiration it will take to achieve this ambitious vision because we are committed to every single person across the country whose life has been touched by lung cancer."
The Partnership's vision to double lung cancer survival by 2022 features four goals backed by solid metrics to ensure quantifiable progress:
"We have always been dedicated to helping lung cancer patients survive as long as possible, but our new vision includes metrics that will make us accountable to those impacted by the disease," said Regina Vidaver, PhD, executive director of the Partnership. "It takes courage to set this unquestionably ambitious target. But with the help of supporters across the country, we're determined to reach it."
Visit www.nationallungcancerpartnership.org/vision to learn more about becoming involved in the Partnership's vision to double lung cancer survival.
The National Lung Cancer Partnership
The National Lung Cancer Partnership is a 501(c)(3) non-profit organization made up of leading doctors, researchers, patient advocates, and lung cancer survivors dedicated to doubling lung cancer survival by 2022. For more information, visit www.nationallungcancerpartnership.org.
©2012 PR Newswire. All Rights Reserved.